Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices

It is observed that the pollution of hospitals is escalated due to the propagation of diseases across the world. The medicine production companies are known as pharmaceutical companies; reserve the different kinds of drug stocks to be supplied to their partners. It is investigated that presently, the patient deaths are hiked due to the delay in drug delivery to hospitals by pharmaceutical companies. It became necessary for pharmaceutical companies to map own supply chain practices, so that the death cases of patients can be eliminated. Pharmaceutical companies are seeking the decision support model with computing technique, which can improve their future performance. The authors propose a model which includes sustainable practices i.e., green, agile, resilient, flexible delivery of medicines. This proposal model is value-added with a weak and strong sustainable practices identification technique. This research deals with an application of a fuzzy-based Incentre of Centroid technique on proposed sustainability and is an assessment model for identifying the ill and strong chief indices, so that pharmaceutical companies can improve performance. An empirical research case of a pharmaceutical firm is presented to exhibit the real-life application of the research work.